Palisade Bio, Inc. (PALI)
NASDAQ: PALI · IEX Real-Time Price · USD
4.735
-0.335 (-6.61%)
Apr 19, 2024, 3:59 PM EDT - Market closed
Palisade Bio Stock Forecast
PALI's stock price has decreased by -83.12% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Palisade Bio stock have an average target of 131.25, with a low estimate of 22.5 and a high estimate of 240. The average target predicts an increase of 2,671.91% from the current stock price of 4.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palisade Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +375.18% | Apr 16, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $23 | Hold → Strong Buy | Upgrades | $23 | +375.18% | Nov 17, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $375 → $240 | Strong Buy | Maintains | $375 → $240 | +4,968.64% | May 16, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $750 | Hold → Strong Buy | Upgrades | $750 | +15,739.49% | Mar 30, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 19, 2022 |
Financial Forecast
Revenue This Year
n/a
from 250.00K
Revenue Next Year
n/a
EPS This Year
-14.61
from -27.00
EPS Next Year
-12.09
from -14.61
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -12.92 | -4.88 | -4.41 | -0.27 | -2.18 |
| Avg | -14.61 | -12.09 | -13.08 | -1.00 | -2.12 |
| Low | -16.02 | -18.67 | -21.02 | -1.68 | -2.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.